Kraj: Irlandia
Język: angielski
Źródło: HPRA (Health Products Regulatory Authority)
ENROFLOXACIN
Bayer Limited
QJ01MA90
ENROFLOXACIN
2.5 %w/v
Solution for Injection
POM
Avian, Canine, Feline, Gerbils, Hamsters, Rabbits, Reptile
Enrofloxacin
Antibacterial
Authorised
1988-10-01
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Baytril 25 mg/ml solution for injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One ml solution contains: ACTIVE SUBSTANCE: Enrofloxacin 25 mg EXCIPIENT: n-Butyl alcohol 30 mg For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for injection. Clear light-yellow solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs, cats, pigs (piglets), rabbits, rodents, reptiles and ornamental birds. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Dogs Treatment of infections of the alimentary, respiratory and urogenital tracts (including prostatitis, adjunctive antibiotic therapy for pyometra), skin and wound infections, otitis (externa/media) caused by enrofloxacin susceptible strains of: _Staphylococcus_ spp_.,_ _Escherichia coli,_ _Pasteurella_ spp_.,_ _Klebsiella_ spp_.,_ _Bordetella_ spp_.,_ _Pseudomonas_ spp_._ and _Proteus_ spp_._ Cats Treatment of infections of the alimentary, respiratory and urogenital tracts (as adjunctive antibiotic therapy for pyometra), skin and wound infections, caused by enrofloxacin susceptible strains of:_ Staphylococcus_ spp_., Escherichia_ _coli, Pasteurella_ spp_., Klebsiella_ spp_., Bordetella_ spp_., Pseudomonas_ spp_._ and_ Proteus_ spp. Pigs (piglets) Treatment of infections of the respiratory tract caused by enrofloxacin susceptible strains of: _Pasteurella multocida,_ _Mycoplasma_ spp_., Actinobacillus pleuropneumoniae_. Treatment of infections of the alimentary tract caused by enrofloxacin susceptible strains of_ Escherichia coli._ Treatment of septicaemia caused by enrofloxacin susceptible strains of_ Escherichia coli_. Rabbits Treatment of infections of the alimentary and respiratory tracts caused by enrofloxacin susceptible strains of: _Escherichia coli_,_ Pasteurella multocida_ and_ Staphylococcus_ spp. Treatment of skin and wound infections caused by enrofloxacin susceptible strains of_ Staphylococcus aureus._ Rodents, reptiles and ornamental birds Treatment of Przeczytaj cały dokument